Positive impact of cladribine on quality of life in people with relapsing multiple sclerosis

BACKGROUND: A number of elements of the pivotal ‘cladribine tablets treating multiple sclerosis orally’ (CLARITY) trial have remained unpublished. OBJECTIVE: To report the impact of cladribine on health-related quality of life (QoL) in people with relapsing multiple sclerosis (pwRMS). METHODS: QoL d...

Descripción completa

Detalles Bibliográficos
Autores principales: Afolabi, Dayo, Albor, Christo, Zalewski, Lukasz, Altmann, Dan R, Baker, David, Schmierer, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174629/
https://www.ncbi.nlm.nih.gov/pubmed/28817997
http://dx.doi.org/10.1177/1352458517726380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174629/
https://www.ncbi.nlm.nih.gov/pubmed/28817997
http://dx.doi.org/10.1177/1352458517726380

Ejemplares similares